Neurocrine Biosciences | NBIX - Pe Prix À Revenus





Pe Changement Date
AbbVie 23.03 1 2026-03
Acadia Pharmaceuticals 10.08 1.53 2026-03
Agios Pharmaceuticals 3.56 0 2026-03
ALKERMES 39.33 19.8 2026-03
Alnylam Pharmaceuticals 80.04 90.66 2026-03
Amgen 19.84 5.47 2026-03
Biogen 13.7 0.32 2026-03
BioMarin Pharmaceutical 15.28 3.96 2026-03
Exelixis 13.91 588.4 2026-03
Gilead Sciences 17.7 2.07 2026-03
Halozyme Therapeutics 11.35 11.8 2026-03
Incyte 15.35 0.51 2026-03
Ionis Pharmaceuticals 396.15 79.28 2022-09
Neurocrine Biosciences 28.09 807.38 2026-03
Pfizer 9.32 5.16 2026-03
Prothena 22.11 11.37 2022-03
Regeneron Pharmaceuticals 25.14 7.03 2026-03
Repligen 109.48 54.58 2026-03
Rigel Pharmaceuticals 8.61 8.4 2025-03
Sarepta Therapeutics 27.27 0 2025-12
Teva Pharmaceutical Industries 10.07 0.04 2026-03
Vertex Pharmaceuticals 25.82 0.33 2026-03
Xoma 52.12 3.09 2022-09